CD69 and acute leukemia: Interestingly, patient-specific enhancers have previously been identified at the CD69 gene in cases of mixed-phenotype acute leukemia.39 Taken together, our data confirm that the differential enhancer regions identified at MEIS1, RUNX2, and CD69 are indeed enhancers for these genes.